If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsiamet Resources Limited Regulatory News (ARS)

Share Price Information for Asiamet Resources Limited (ARS)

Share Price is delayed by 15 minutes
Get Live Data
1.575    0.00 (0.00%)
Bid:
1.55
Ask:
1.60
Spread: 0.05 (3.226%)
Market Cap: £53.45m
ARS Live PriceLast checked at - London Stock Exchange

Intraday Asiamet Resources Limited Share Chart

Director Appointment

10 Jul 2019 07:05

RNS Number : 0531F
Asiamet Resources Limited
10 July 2019
 

 

10 July 2019

 

Asiamet Director Appointment

Asiamet Resources Limited ("Asiamet" or the "Company") is pleased to announce the appointment of Mr Feng (Bruce) Sheng as a Non-Executive Director to the Board effective from 10 July 2019. Mr Sheng is the Chairman of Melbourne based Asipac Group Pty Ltd, a diversified company with investments across the resources and financial sectors, and various property businesses. Mr Sheng also currently serves as Vice Chairman of the Australia China Business Council (Victoria) and the Executive Chairman of ASX listed Terramin Australia Ltd, a company developing a portfolio of zinc and gold projects in Australia and Algeria.

 

Tony Manini, Executive Chairman commented:

"On behalf of the Company we welcome Bruce to the Asiamet Board. Bruce has been a long-term supportive shareholder and we look forward to the opportunity to work more closely with him as we move into the project financing and development stage for the BKM project and continue advancing our other high potential projects on the KSK CoW and at Beutong. Bruce has spent the past 25 years working at the interface between China-Australia business and brings extensive experience and networks across China and greater Asia to the Asiamet board. This is particularly relevant given China's One Belt-One Road policy and the large amount of Chinese inbound investment into Indonesia associated with it. Enhancing the Company's level of connectivity with China is expected to add significant value as we continue the development of our portfolio of high-quality copper, gold and polymetallic projects. Different skills and experience will be required to take the Company forward and as such further evolution and strengthening of the board and management team is considered an important requisite for continued growth. Our ability to attract new directors of the calibre of Bruce, and Dominic before him, are testament to the progress we have made and the quality of the growth opportunity that Asiamet presents for investors. We look forward to continuing to deliver on our plans for the benefit of all stakeholders."

The Company provides the following additional disclosure as at 10 July 2019 relating to the appointment of Mr Feng (Bruce) Sheng as director of Asiamet, effective 10 July 2019:

Mr Feng (Bruce) Sheng, aged 56, currently holds or has held the following directorships and partnerships over the last five years:

Current directorships and partnerships

Past directorships and partnerships

Asipac Group Pty Ltd

Sinotrans Investments Pty Ltd

Asipac Capital Pty Ltd

Sinotrans Holdings Pty Ltd

Asia Pacific Hotels Pty Ltd

Retakaful Collective Pty Ltd

Asipac Holdings Pty Ltd

1st Fund Capital Pty Ltd

Terbru Pty Ltd

 

Kinjusca Pty Ltd

 

Asipac FS Investments Pty Ltd

 

Asipac Corporation Pty Ltd

 

Asipac Dairy Pty Ltd

 

BMY Group Pty Ltd

 

Partyworld International Pty Ltd

 

AHA Pacific Pty Ltd

 

Wanshe Holdings Pty Ltd

 

Terramin Australia Limited

 

Western Mediterranean Zinc SpA

 

Mr. Sheng, through the holdings of Asipac Group, has an 8.55% interest in the securities of Asiamet at the date of this announcement.

Except as disclosed in this announcement, neither the Company nor Mr. Sheng are aware of any further disclosures that are required in respect of the appointment of Mr. Sheng under Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

ON BEHALF OF THE BOARD OF DIRECTORS

Tony Manini, Executive Chairman

 

For further information, please contact: 

-Ends-

Peter BirdDeputy Chairman and CEO, Asiamet Resources LimitedTelephone: +61 3 8644 1300Email: peter.bird@asiametresources.com

 

Tony ManiniExecutive Chairman, Asiamet Resources LimitedTelephone: +61 3 8644 1300Email: tony.manini@asiametresources.com

 

FlowComms Limited

Sasha Sethi

Telephone: +44 (0) 7891 677 441

Email: Sasha@flowcomms.com 

Asiamet Resources Nominated AdviserRFC Ambrian Limited

Andrew Thomson / Stephen Allen

Telephone: +61 8 9480 2500

Email: Andrew.Thomson@rfcambrian.com / Stephen.Allen@rfcambrian.com 

 

Berenberg

Matthew Armitt, Detlir Elezi

Telephone: +44 20 3753 3142

Email: Matthew.Armitt@berenberg.com / Detlir.Elezi@berenberg.com

 

LiberumClayton Bush, Kane Collings

Telephone: +44 7773 322679

Email: Claytong.Bush@liberum.com 

 

Optiva Securities LimitedChristian Dennis

Telephone: +44 20 3137 1903

Email: Christian.Dennis@optivasecurities.com

 

Follow us on twitter @AsiametTweets

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEBLBFKDFEBBD
Date   Source Headline
11th Dec 202011:00 amRNSCorporate Update – KSK Sale Process
16th Nov 202011:05 amRNSSecond Price Monitoring Extn
16th Nov 202011:00 amRNSPrice Monitoring Extension
13th Oct 202010:09 amRNSMedia and Presentation Links
8th Oct 20204:41 pmRNSSecond Price Monitoring Extn
8th Oct 20204:36 pmRNSPrice Monitoring Extension
8th Oct 20202:06 pmRNSSecond Price Monitoring Extn
8th Oct 20202:00 pmRNSPrice Monitoring Extension
8th Oct 202011:05 amRNSSecond Price Monitoring Extn
8th Oct 202011:00 amRNSPrice Monitoring Extension
8th Oct 20209:05 amRNSSecond Price Monitoring Extn
8th Oct 20209:00 amRNSPrice Monitoring Extension
8th Oct 20207:00 amRNSHeads of Agreement Signed for KSK
7th Sep 20209:35 amRNSAppointment of Crowe U.K. LLP as Auditor
28th Aug 20208:05 amRNSAppointment of Chief Financial Officer
20th Aug 20207:02 amRNS2020 Interim Financial Statements
13th Aug 202010:30 amRNSIssue of Director Performance Rights
7th Aug 202011:49 amRNSLink to Investor Call and Q&A
17th Jul 20201:32 pmRNSAsiamet Responds to Media Article
3rd Jul 202012:05 pmRNSAGM 2020 Q&A Session
30th Jun 20205:25 pmRNSResult of AGM
26th Jun 202010:50 amRNSCorporate Update
22nd Jun 20203:55 pmRNSAnnual General Meeting Update
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
28th May 20204:00 pmRNSNotice of Annual General Meeting
26th May 202011:05 amRNSSecond Price Monitoring Extn
26th May 202011:00 amRNSPrice Monitoring Extension
26th May 20208:45 amRNSCorporate Update
15th May 20209:05 amRNSSecond Price Monitoring Extn
15th May 20209:00 amRNSPrice Monitoring Extension
15th May 20207:00 amRNSAsiamet Receives Key Approval for BKM Project
5th May 20207:10 amRNS2019 Annual Report & Financial Statements
28th Apr 20209:01 amRNSKSK Receives Key Exploration Permit
7th Apr 20202:06 pmRNSSecond Price Monitoring Extn
7th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Mar 20204:00 pmRNSCorrection of Admission Date
25th Mar 202010:22 amRNSStrategic Investment and Development Partner
25th Mar 20209:05 amRNSSecond Price Monitoring Extn
25th Mar 20209:00 amRNSPrice Monitoring Extension
13th Mar 20209:46 amRNSAsiamet Business Update
10th Mar 20202:05 pmRNSSecond Price Monitoring Extn
10th Mar 20202:00 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSRelocates Head Office to Jakarta, Indonesia
10th Dec 20194:40 pmRNSSecond Price Monitoring Extn
10th Dec 20194:35 pmRNSPrice Monitoring Extension
10th Dec 20197:00 amRNSCompany Update
26th Nov 20197:00 amRNSKSK Exploration Update
13th Nov 201910:00 amRNSIssue of Shares to Consultant
12th Nov 20197:00 amRNSDirector Purchase of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.